Autres langues Amgen Inc.

Actions

AMGN

US0311621009

Produits pharmaceutiques

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 24/07/2026			Varia. 5j.	Varia. 1 janv.
376,04 ^USD	+1,22%		+2,66%	+14,89%

24/07	Amgen soumet de nouvelles données pour contester la proposition de la FDA de retirer le Tavneos	RE
24/07	CuraTeQ Biologics obtient un avis favorable de l'Agence européenne des médicaments pour son biosimilaire du Neulasta	MT

Autres langues

24/07	Amgen submits new data to challenge FDA's proposal to withdraw Tavneos
24/07	WOCHENVORSCHAU/3. August bis 9. August 2026 (32. KW)
24/07	Amgen : Statement on FDA Data Submission for TAVNEOS® (avacopan)
24/07	CuraTeQ Biologics Wins European Medicines Agency's Positive Opinion for Neulasta Biosimilar
22/07	Amgen Reportedly to Pay $74 Million to Settle Shareholder Suit Over Delayed IRS Tax Disclosure
21/07	Amgen settles shareholder lawsuit claiming it hid $10.7 billion tax bill
17/07	Gestern an der Wall Street: Halbleitersektor belastet die Börsen
17/07	Ayer en Wall Street: los semiconductores lastran el cierre de la jornada
16/07	Merck & Co erhält US-Zulassung für neuartige Cholesterin-Pille
16/07	Merck gets US FDA nod for first-in-its-class oral cholesterol drug
08/07	Amgen Ecovation®: How Amgen Builds Sustainability Into Biotech
08/07	Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says
07/07	Weight-loss drug developers line up to tap lucrative market as competition heats up
04/07	Amgen Inc. Announces Product Recall
04/07	Amgen, Inc. Announces Product Recall
04/07	Amgen Inc Recalls Sensipar Tablets 30 mg, 30-Count Bottles Due to CGMP Deviations
04/07	Amgen Inc Announces Product Recall
04/07	Amgen Recalls Corlanor Tablets Due to Presence of Foreign Substance
03/07	Regeneron gegen Amgen: Eylea mitten im Ring
02/07	Amgen Wins Preliminary Injunction to Block Colorado From Imposing Price Cap on Arthritis Drug
02/07	Regeneron frente a Amgen: Eylea en el centro del ring
02/07	Roche-Hoffnungsträger Divarasib überzeugt in Lungenkrebs-Studie
02/07	Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial
01/07	Regeneron vs. Amgen: Eylea in het midden van de ring
01/07	Judge blocks Colorado's first-of-its-kind price cap on Amgen's Enbrel